Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

On call > Amanda C notes II > Flashcards

Amanda C notes II Flashcards

1
Q

TG142 MLC test tolerances

A

-picket fence (weekly)
-setting vs radiation field- 2 mm (monthly)
-loss of leaf speed < 0.5 cm /s (monthly)
-leaf positioning accuracy 1 mm (monthly, picket fence)
-MLC transmission (0.5 % from baseline, annual)
-leaf position repeatability 1 mm (annual)
-MLC spoe shot radius 1 mm (annual)
-coincidence of light field and xray field 2 mm (annual)
-gamma test, < 0.35 cm max, error RMS 95% of error counts < 0.35 cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Co-60 dmax, PDD10

A

0.5 cm, 59%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

surface dose for 5x5 cm2 PFF vs 40x40 cm2 PDD

A

20% vs 40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SSD effect on PDD

A

2%/cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

temperature error/degree

A

0.3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pressure error/kPa

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how often are wedge factors checked?

A

daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CPQR gamma tolerance

A

tolerance is 95% < 3%/3 mm
action is 95%< 5%/3mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

key points about scanning water tank

A

-centered
-orthogonal
-level
-accurate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

tolerance for ion chamber extra cameral signal, signal reproducibility, stem effect

A

0.5% tolerance, 1 % action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

tolerance for ion chamber leakage

A

0.1%, 0.2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

tolerance for ion chamber reproducibility

A

1%,2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pion should be less than…

A

1.05
2.-use another chamber if this isn’t the case; don’t increase voltages just to reduce it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

internal shielding- how to protect against electron backscatter

A

coat in Al around Pb shield and dip in wax to form 1-2 mm coating around Pb. Reduces low energy backscattered electrons to patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In ortho, layers of Pb required to reduce transmission to <5% of max dose

A

1 layer reduces 100 kV to 1 %, 180 to 3.5% and 300 to 21%
2 layers reduces 100 to 0.1%, 180 to 0.6%, and 300 to 8.6%
3 layers reduces 300 to 4.2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

sources of uncertainty in RT

A

-patient localization
-imaging
-anatomical definition
-beam geometry establishment
-dose calculation
-dose display and plan evaluation
-plan implementation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

things to test in TPS

A

-Contour dimensions
-CT to RED conversion
-dosimetric cases for:
-standard geometry
-olbique, lack of scattering, tangential fields
-significant blocking
-four field box, three fields, wedges
-customized blocking
-non-coplanar beams and collimator rotation

-standard geomet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how to evaluate 3rd party software?

A

-cost
-evaluate what you do in clinic (can it do VMAT, IMRT. multiple iso etc)
-QA each modality
-can it produce reports
-dicom compatible
-import/export

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

main responsibilities of RSO

A

-education (radiation safety training) and for non NEW staff as well
-monitoring and recording
-licensing
-respond to emergencies and incidents
-develop, maintain, and enforce procedures
-radiation safety program
-must promote safety culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how to estimate dose to fetus

A

out-of-field profiles based on distance from field edge
-10% at 2 cm
-1% at 10 cm
-0.1% at 30 cm

5 cGy is lowest dose with little risk of damage

21
Q

risk of damage to detus from RT

A

< 5 cGy little risk
5-10 cGy uncertain
10-50 cGy sigificant risk if during first trimester
>50 cGy high risk during all trimester

22
Q

considerations for RT of preganant patient

A

contributions for fetal dose:

> > 10 MV- contribution from neutrons coming from head
-photon leakage through treatment head
-scatter radiation from collimators and beam modifiers
radiation scattered within patient from treatment beam
-imaging

-reduse high energy use
-modify technique to reduce dose
-special shield (bridge over patient)
-shielding designed to reduce head scattering
-low dose imaging where [possible

23
Q

issues with small field size dosimetry

A

-direct photon beam source is occluded- get overlapping penumbra and lowers output- widens FWHM of profile- FWHM might not be proper description of FS
-lack of lateral electronic equilibrium
-detector is large- can’t resolve the prnumbra and also perturbs fluence at point of measurement

24
Q

types of sites being treated by brachy

A

Intracavitary: Uterine cervix, Corpus uteri, Vagina
Interstitial: Head and Neck, Breast, Prostate Gland
Interaluminal: Bronchus and Oesophagus
Superficial brachytherapy: Surface or mould

25
Q

brachy sources

A
26
Q

ideal brachy source characteristics

A

Energy: should be high enough to be penetrating and not to have too many photoelectric interactions, but should not be too high so that radiation protection requirements are minimized
Half-life: Should be long enough so it is practical to use the source and that the decay is a minor effect on the treatment time calculation, but it should be short enough so not to be a radiation safety hazard
Charged particle emission: Should be minimized so that the dose rate very close to the source is not too high (α and β particles are too short in range and only result in very high doses to small volumes around the source)
Gaseous disintegration products: i.e. should not give off Radon
Should be insoluble and non-toxic
No Powdering or dispersion if incinerated
Should be available in a variety of shapes and sizes: ease of use in clinical situations
Should be resistant to damage during sterilization

27
Q

shielding of remote afterloader must meet what condition?

A

air kerma rate 1 µGy h-1 at 1 m

28
Q

Cs-137 activity for LDR

A

10 mCi

29
Q

Acceptance and Commissioning of a HDR unit:Acceptance: Purpose of acceptance is to test that the HDR unit:

A

Meets safety standards:
Interlocks, signage, emergency functionality, radiation surveys of afterloader
Meets contractual specification of the unit:
Positional accuracy, timing accuracy, source activity, TPS functionality and integration
Scope of acceptance tests generally determined by vendor, unless previously agreed upon
Commissioning:
Acquire and test accuracy of all system-specific parameters in the treatment planning process
Entry of acquired data into to TPS and testing of dosimetric accuracy and end-to-end (E2E) process Development of operational and quality control procedures
Training of all staff involved
Image guidance system, e.g. ultrasound, should ideally be commissioned prior to afterloader for E2E testing

30
Q

brachy TPS tests

A

-overall system test
-geometrical accuracy (source input and display)
-optimization performance
-time and dose calculation accuracy
-isodose accuracy
-DVH and figures of merit
-dose and position constancy under plan rotation
-coordinate reconstruction accuracy
-input parameters (Verify parameters for all pre-calculated single-source arrays against publish recommendations and source vendor’s mechanical drawing)
-verify consistency of printed plan documentation
-dicom import from ct

31
Q

dose drop-off in brachy

A

IS for high E source
faster than IS for low E source (I125, Pd103)

32
Q

evolution of TG43

A

pre TG43- specific source construction not addressed, problems at low energy, calculations based on apparent activity, sievert integral
Many problems with above formalism (specific source construction not addressed, problems at low energy)
TG-43:
Use dose rate constants that are specific to source design & directly measured/calculated (MonteCarlo). Also use consensus data for low E sources

33
Q

brachy radial dose functions

A
34
Q

Behaviour of F(r,theta)

A

While F(r, θ) on the transverse plane is defined as unity, the value of F off the transverse plane typically decreases as
r decreases
as θ approaches 0° or 180°
as encapsulation thickness increases
as photon energy decreases

35
Q

brachy program design considerations

A

A multidisciplinary team is required: nurses, RT, physicists, dosimetrists, radiation oncologists, administrators and engineers. The physicist serves as the leader of the team with respect to planning and treatment delivery, determining which tasks and quality assurance checks can be delegated to team members.
Need to establish the expected patient population and the types of procedures that will be performed
Facility design begins with specification of sources, applicators, delivery systems, imaging, treatment planning software etc. Allocated space must meet the shielding requirements
Physicist are also responsible for acquiring the licensing for the proposed facility with the appropriate regulatory agency
Acceptance & commissioning
Develop treatment planning and QA protocols
Training
Shielding

36
Q

physics role in brachy program design

A

Design and implement a brachytherapy facility that meets the clinical needs of the institution
Develop and implement treatment delivery procedures (for each clinical site and type of brachytherapy procedure) that accurately realize the clinical intent of the radiation oncologist, protect the patient from treatment delivery errors, maximize safety of the patient and staff, and, finally, minimize the legal and regulatory liability of the institution
Ensure the accuracy and safety of each individual brachytherapy treatment through review of calculations, monitoring treatment team compliance to established procedures, and adapting procedures to meet the needs of unusual patients

37
Q

LDR prostate constraints to urethra and rectum interface

A

urethra < 360 Gy
rectum interface < 90 Gy

38
Q

heterogeneities in prostate brachy

A

calcified deposits in prostate gland

39
Q

rectum and bladder dose in manchester gyne brachy

A

keep <80% of pt A dose

40
Q

high risk CTV

A

GTV + whole cervix

41
Q

intermediate risk CTV

A

high risk CTV +0.5-1.5 cm margin

42
Q

low risk CTV

A

intermdiate risk CTV + uterus + parametria + vagina

43
Q

radiation safety committee

A

advise RSO and manaement on quality and effectiveness of radiation safety program

44
Q

Design of SBRT program

A

-assemble inter. team
-determine clinical goals (site, fractionation)
-assemble documents (ASTRO, TG etc) and read liteature
-delivery technique, energy, motion management immobilization, IGRT
-proper dosimetry equipment
-design QA program, protocols and procedures
-training
-external audit
-regular review for improvement
-also maybe visit a site doing the technique

45
Q

ALARA in IGRT

A

-protocols specific to pediatric
-local imaging protocols
-kV lower than MV
-use collimation to reduce tissue exposed

46
Q

ICRP risk of inducing a fatal cancer from a single radiograph

A

5*10^-5/mSv

47
Q

effective dose from CT head and CT body

A

2-4 mSv head
5-15 mSv body

versus 50 mGy CTDI head and 15-25 mGy CTDI body

48
Q

effective dose xray

A

fluoro 0.01- 0.05 mSv
chest xray 0.01-0.05 mSv
skull xray 0.1- 0.2 mSv
mammo 0.05 mSv
abdo xray 1 mSv

49
Q

effective dose kVCBCT

A

1.1-24 mSv for trunk
0.04-9.4 mSv for head and neck

On call (23 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions